Catalent Inc. (CTLT)
NYSE: CTLT
· Real-Time Price · USD
63.48
0.00 (0.00%)
At close: Dec 17, 2024, 9:00 PM
0.00% (1D)
| Bid | n/a |
| Market Cap | 11.52B |
| Revenue (ttm) | 4.42B |
| Net Income (ttm) | -413M |
| EPS (ttm) | -2.28 |
| PE Ratio (ttm) | -27.842105263157894 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | n/a |
| Volume | 13,674,041 |
| Avg. Volume (20D) | 2,268,467 |
| Open | 63.49 |
| Previous Close | 63.48 |
| Day's Range | 63.44 - 63.50 |
| 52-Week Range | 42.11 - 63.50 |
| Beta | 1.16 |
About CTLT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTLT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CTLT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Catalent Inc. is scheduled to release its earnings on May 2, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago · proactiveinvestors.com
Lisata Therapeutics talks ADC breakthrough with Catalent – ICYMILisata Therapeutics Inc earlier this week discussed the potential of certepetide in antibody-drug conjugate (ADC) applications through a new collaboration with Catalent. The company told investors tha...
